Partners in crime – genes ATP13A2 and GBA1 interact to drive neurodegeneration
The findings reveal promising biological pathways that could be explored in future therapies.
Read More
The findings reveal promising biological pathways that could be explored in future therapies.
Read MoreThe findings have provided answers to families that until now had no diagnosis for their child’s condition.
Read MoreGrowing and maintaining norovirus strains in the lab allows researchers to advance studies of viral structure, antiviral drug screening and vaccine development.
Read MoreDifferences in these genes help explain why Epstein-Barr Virus can have lasting health effects in some people but not others.
Read MoreTumor cells that were frequently undetectable using standard markers became clearly visible when the team applied the new marker combination.
Read MoreThis study opens the door to new strategies for potentially slowing or preventing VCP-linked neurodegeneration.
Read MoreThe findings offer new possibilities to restore in people disruptions in dopamine that have been associated with disorders such as addiction, depression, sleep disorders and schizophrenia.
Read MoreRosenberg’s proposal was chosen for her groundbreaking strategy to combat antibiotic resistance by targeting the evolutionary process itself.
Read MoreThis novel immunotherapy may help the immune system recognize and attack cancer cells in a way that other immunotherapies have not been able to do thus far.
Read MoreThis study not only uncovered a key mechanism but points at new ways to develop treatments that could make a difference in people living with DM1.
Read More